Research Reports

image56

Ludlow Investor Mailing List

Join for research updates and investment alerts

Riot Blockchain (NASDAQ:RIOT)

 Riot Blockchain (NASDAQ: RIOT) specializes in cryptocurrency mining with a focus on bitcoin. Riot also holds non-controlling investments in blockchain technology companies. Riot is headquartered in Castle Rock, Colorado, and the Company’s primary mining facility is located in Oklahoma City, Oklahoma. For more information, visit www.RiotBlockchain.com  

Coverage Highlight: RIOT is positioned for upside interest as demand for bitcoin grows as an alternative investment to Gold and US Treasuries.
Short-term Target: $4.00 to $5.00

Updated: May 15, 2020 (pdf)

Download

GTX Corp (OTC:GTXO)

 GTX Corp (OTC: GTXO) is a pioneer in smart, mobile and wearable GPS tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. GTX offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications. GTX Corp utilizes the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC and BLE technology, enabling subscribers to track in real time the whereabouts of people or high value assets. GTX Corp’s business model is built around technology innovation and holds over 85 patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers in over 35 countries and is a U.S. Military Government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers. www.GTXCorp.com

Coverage Highlight: GTXO offers GPS tracking technology that could potentially be used in contact tracing in helping reopen economy during coronavirus outbreak.
Price Target: $0.05 to $0.08

Updated: April 19, 2020 (pdf)

Download

Hammer Fiber (OTCQB:HMMR)

 Hammer Fiber Optics Holdings Corp. (OTCQB:HMMR) is a telecommunications company investing in the future of wireless technology. Hammer’s “Everything Wireless” go to market strategy includes the development of high-speed fixed wireless service for residential and small businesses using its wireless fiber platform, Hammer Wireless® AIR, Over-the-Top services such as voice, SMS and video collaboration services, the construction of smart city networks and hosting services including cloud and colocation. www.hammerfiber.com

Target: $0.50+ (speculative)

Updated: Feb. 17, 2020 (pdf)

Download

SinglePoint - Direct Solar (OTC:SING)

 Direct Solar of America is a subsidiary of SinglePoint Inc. (OTCQB: SING). Direct Solar of America, a solar energy brokerage, helps find and install the best available solar energy system for any building, residential or commercial. https://directsolaramerica.com/

 Target: $0.015 - $0.02

Updated: Feb. 12, 2020 (pdf)

Download

ChineseInvestors.com (OTCQB:CIIX)

 Founded in 1999, ChineseInvestors.com (OTCQB:CIIX)  endeavors to be an innovative company providing: (a) real-time market  commentary, analysis, and educational-related services in Chinese  language character sets (traditional and simplified); (b) advertising  and public relation-related support services; and (c) retail, online and  direct sales of hemp-based products and other health-related products.  For more information visit www.chineseInvestors.com
 

Updated: Nov. 12, 2019 (pdf)

Download

Auris Medical Holding (EARS)

  •  Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental disorders supportive care. The company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). This program is currently in Phase 1. In addition Auris Medical has two Phase 3 programs under development: AM-111 for sudden sensorineural hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus. 

Updated: Oct. 18, 2018 (pdf)

Download